Premier Diagnostic Health Services Inc.: News Release-Private Placement Extended

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 27, 2012) - Premier Diagnostic Health Services Inc. ("PDH") (CNSX:PDH) today announced that it is extending its May 31, 2012 offering to accredited investors. The previously announced offering consisted of 16,250,000 units at $0.08 per unit for aggregate proceeds of $1,300,000. Each unit consisted of one (1) share of PDH and one (1) warrant.

The revised terms of the extended offering are: each unit will be sold at a price of $0.10 per unit, with each unit consisting of one (1) share of PDH and one (1) warrant. Two (2) warrants are required for the purchase of an additional share at $0.15 per share. The warrants are non-transferable and will expire September 30, 2013. Minimum purchase is $20,000.

This extended offering will expire at 2:00 p.m. on October 31, 2012, (rather than July 31, 2012). The company may carry out periodic closings during the term of the offering.

The funds will be used to facilitate the Company's business plan and to implement the work and procedures necessary to fulfill the requirements relating to obtaining a listing on a senior market.

More details about the business plan, term sheet, subscription form, and authorized representatives are available on the company's website at www.premierdiagnostics.ca.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier. (Not for dissemination in the United States of America).

About Premier Diagnostic Health Services Inc. ("PDH")

Premier is a Canadian company accelerating international access to advanced medical diagnostic tools and skills. The company's vision is to provide services and partnership opportunities that support "improving medical decisions" around the world. The company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' diagnostic capacity and capability.